Option Care Health, Inc. (NASDAQ:OPCH) Holdings Increased by AlphaQuest LLC

AlphaQuest LLC grew its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 417.8% during the fourth quarter, Holdings Channel reports. The institutional investor owned 23,520 shares of the company’s stock after acquiring an additional 18,978 shares during the period. AlphaQuest LLC’s holdings in Option Care Health were worth $546,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in OPCH. UMB Bank n.a. lifted its stake in Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock valued at $27,000 after purchasing an additional 346 shares during the last quarter. Quarry LP lifted its stake in Option Care Health by 327.7% during the third quarter. Quarry LP now owns 3,430 shares of the company’s stock valued at $107,000 after purchasing an additional 2,628 shares during the last quarter. Blue Trust Inc. lifted its stake in Option Care Health by 16.9% during the fourth quarter. Blue Trust Inc. now owns 4,703 shares of the company’s stock valued at $109,000 after purchasing an additional 681 shares during the last quarter. Venturi Wealth Management LLC lifted its stake in Option Care Health by 2,621.3% during the fourth quarter. Venturi Wealth Management LLC now owns 4,735 shares of the company’s stock valued at $110,000 after purchasing an additional 4,561 shares during the last quarter. Finally, KBC Group NV lifted its stake in Option Care Health by 16.2% during the third quarter. KBC Group NV now owns 5,013 shares of the company’s stock valued at $157,000 after purchasing an additional 700 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research firms recently commented on OPCH. JMP Securities reissued a “market outperform” rating and set a $30.00 target price (down from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. UBS Group began coverage on shares of Option Care Health in a research note on Thursday, December 5th. They set a “neutral” rating and a $26.00 target price for the company. Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and increased their target price for the company from $26.00 to $33.00 in a research note on Monday, January 13th. Jefferies Financial Group upgraded shares of Option Care Health from a “hold” rating to a “buy” rating and boosted their price target for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. Finally, JPMorgan Chase & Co. boosted their price target on shares of Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a report on Thursday, March 6th. Two equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $33.00.

Option Care Health Stock Down 1.6 %

OPCH stock opened at $32.89 on Thursday. The firm has a market capitalization of $5.44 billion, a P/E ratio of 27.64, a P/E/G ratio of 2.30 and a beta of 1.33. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The company’s 50 day simple moving average is $30.44 and its 200-day simple moving average is $28.22. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $34.85.

Insider Buying and Selling at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the company’s stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the transaction, the insider now owns 44,974 shares in the company, valued at approximately $1,495,835.24. This represents a 40.80 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.64% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.